Probiotic supplement for long-standing type 1 diabetes
Part of Hormones & metabolism, Immune system & allergy clinical trials.
This study tests whether taking a specific probiotic (a beneficial bacteria) for 4 weeks can improve immune function and metabolism in people who have had type 1 diabetes for at least 5 years. Researchers believe this probiotic may help the body's remaining insulin-producing cells work better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18 or older
- Type 1 diabetes diagnosed more than 5 years ago with certain antibody markers
- Some remaining insulin-producing ability (tested by C-peptide levels)
- BMI between 18 and 30 (healthy weight range)
- No antibiotics, proton-pump inhibitors, or other probiotics in past 3 months
- No inflammatory bowel disease, recent gallbladder removal, or serious kidney/liver disease
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if taking inulin, a type of fiber, can help improve blood sugar control and immune health in people with type 1 diabetes. Participants will take a daily supplement for a period of time to see if it makes a difference.
This trial tests whether taking a vitamin supplement called 5-MTHF (a form of folate) can help preserve remaining insulin-making ability in people with type 1 diabetes. It may slow the loss of insulin function, making diabetes easier to manage.
This study tests if taking capsules with processed donor stool can help preserve insulin-making cells in people recently diagnosed with type 1 diabetes. The treatment aims to slow the loss of insulin production.
This study tests whether taking a probiotic supplement (a product with helpful bacteria) can improve blood sugar control and gut health in people with type 1 diabetes. It involves taking the supplement, providing stool and blood samples, and attending follow-up visits.
This study looks at children who have just started insulin for new-onset type 1 diabetes. It aims to test an intervention early in the course of the disease, which may help change how the immune system and diabetes progress.
This study tests whether a specific beneficial bacteria supplement (called Lactobacillus paracasei LC19) can help control blood sugar in people with newly diagnosed type 2 diabetes. It may offer an option to manage diabetes without starting medication right away.
Hear when a new Type 1 Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.